RE:RE:Fsd Pharma Renofund wrote:
DavidRosenberg wrote: Has moved on from the unprofitable cannabis industry and is focused on strong IP in the drug development world
unprofitbale? I think you need to take a closer look. There are MANY profitable companies making money in the cannabis sector. In fact, if you take a price/sales metric, etc, one of the most undervalued based on sales. As well, sales growth is quite strong. Sure, the garbage microcap companies you were trying to promote were just shells, so of course that is what you base it on. From a pure probability standpoint, you have a better chance making a profit in cannabis than in bio-tech. They moved on becuase they raised some money in a hot sector (at the time) and realized they couldnt do it. They pivot from one hot idea to the next. Rosie, YOU are paying for the 1MM zoom calls and only getting a capital loss carry forward for your efforts. That is, unless it is in your TFSA or RSP, then it has NO benefit.
Yep, no profit in cannabis. Do you even think before you speak, or type rather. https://www.forbes.com/sites/dariosabaghi/2021/12/20/pfizer-to-enter-the-medical-cannabis-industry-with-67-billion-acquisition/?sh=500475d86072&s=09